Author

L. S. Gensler

Observed names: L S Gensler, L.S. Gensler, LS Gensler

Institution: University of California, San Francisco

Observed institutions: University of California, San Francisco, University of California San Francisco Medical Center

OpenAlex ID: A5010216635

Clinical, radiographic and functional differences between juvenile-onset and adult–onset ankylosing spondylitis: results from the PSOAS cohort

2007 · L S Gensler, M M Ward, et al. · Annals of the Rheumatic Diseases · 95

Op0023 a Randomized, Double-blind Trial Comparing Secukinumab 300 Mg and 150 Mg at Week 52 in Patients With Ankylosing Spondylitis Who Did Not Achieve Inactive Disease During an Initial 16 Weeks of Open-label Treatment With Secukinumab 150 Mg

2022 · A. Deodhar, A. Kivitz, et al. · Annals of the Rheumatic Diseases · 3

PDF

Pos0773 Low Uveitis Rates in Patients With Axial Spondyloarthritis or Psoriatic Arthritis Treated With Bimekizumab: Long-term Results From Phase 2b/3 Trials

2025 · I. van der Horst-Bruinsma, M. Brown, et al. · Annals of the Rheumatic Diseases · 2

Pos0806 Long-term Sustained Efficacy and Safety of Bimekizumab Across the Full Spectrum of Axial Spondyloarthritis: 2-year Results From Two Phase 3 Studies

2024 · X. Baraliakos, A. Deodhar, et al. · Annals of the Rheumatic Diseases · 2

Pos0391 the Msquash as Measurement Tool for Daily Physical Activity: Translation and Cross-cultural Adaptation Into English, Field-testing in Different Rheumatic Diseases and Clinical Validation in Patients With Axial Spondyloarthritis

2024 · Y.M. Van der Kraan, L.S. Gensler, et al. · Annals of the Rheumatic Diseases · 2

Pos1255 Reactogenicity of Sars-cov-2 Vaccines in Patients With Autoimmune and Inflammatory Disease

2021 · M. Yang, P. Katz, et al. · Annals of the Rheumatic Diseases · 2

PDF

Op0060 Machine Learning Based Berlin Scoring of Magnetic Resonance Images of the Spine in Patients With Ankylosing Spondylitis From the Measure 1 Study

2020 · A. Jamaludin, R. Windsor, et al. · Annals of the Rheumatic Diseases · 2

PDF

SAT0465 An integrated safety data analysis across all phase ii and phase iii clinical programs for ustekinumab in psoriatic arthritis, crohn's disease, and psoriasis

2017 · LS Gensler, E Hsia, et al. · Annals of the Rheumatic Diseases · 2

PDF

2024 · L. Eder, A. Gao, et al. · Annals of the Rheumatic Diseases · 1

Pos0498 Associations Between Extra-musculoskeletal Manifestations and Radiographic Progression in Axial Spondyloarthritis

2024 · S.S. Zhao, N. Harvey, et al. · Annals of the Rheumatic Diseases · 1

Op0103 Comorbidity Burden and Radiographic Progression in Axial Spondyloarthritis

2024 · S.S. Zhao, N. Harvey, et al. · Annals of the Rheumatic Diseases · 1

Thu0384 Impact of Ixekizumab on Work Productivity in Non-radiographic Axial Spondyloarthritis Patients: Results From the Coast-x Trial at 52 Weeks

2020 · A. Deodhar, P.J. Mease, et al. · Annals of the Rheumatic Diseases · 1

Le bimekizumab a démontré une efficacité comparable à 1 an chez les hommes et femmes atteints de spondyloarthrite axiale : résultats de deux études de Phase III

2025 · A. Molto, M. Rudwaleit, et al. · Revue du Rhumatisme

Pos0864 Achievement of Remission Defined by Absence of Objective Signs of Inflammation Versus Asdas Inactive Disease in Patients With Active Axial Spondyloarthritis Treated With Bimekizumab: 52-week Results From Two Phase 3 Studies

2025 · M. Rudwaleit, H. Marzo-Ortega, et al. · Annals of the Rheumatic Diseases

Pos0118 Asas Recommendations on Reporting Outcomes of Core Outcome Set Instruments in Axial Spondyloarthritis Clinical Trials

2025 · F. van Gaalen, V. Navarro-Compán, et al. · Annals of the Rheumatic Diseases

Abs0273 New Pathogenic Pathways in Ankylosing Spondylitis Identified Through Multi-ancestry Genomewide Association Study

2025 · Z. Li, N. Harvey, et al. · Annals of the Rheumatic Diseases

Faible taux d’uvéites chez les patients atteints de spondyloarthrite axiale ou de rhumatisme psoriasique traités par bimekizumab : résultats à long terme des essais de phase IIb/III

2024 · C. Miceli Richard, I.E. Van Der Horst-Bruinsma, et al. · Revue du Rhumatisme

Pos0501 Gender and Age-of-onset Are Associated With Radiographic Progression in Axial Spondyloarthritis

2024 · S.S. Zhao, N. Harvey, et al. · Annals of the Rheumatic Diseases

Ab0913 Efficacy of Certolizumab Pegol in Preventing Anterior Uveitis Flares Compared With Standard Non-biologic Treatment: a Matched Control Study in High-risk Patients With Axial Spondyloarthritis

2024 · N. Haroon, Z. Baskurt, et al. · Annals of the Rheumatic Diseases

Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante active : résultats à 5 ans d’une étude de phase IIb et de son extension en ouvert

2023 · M. Dougados, A. Deodhar, et al. · Revue du Rhumatisme

Pos0665 Incidence Rate and Factors Associated With Fractures Among Adults With Ankylosing Spondylitis in the United States

2023 · R. Stovall, E. Kersey, et al. · Annals of the Rheumatic Diseases

PDF

Le bimékizumab améliore les principaux symptômes rapportés par les patients atteints de spondylarthrite axiale, notamment les douleurs rachidiennes et la fatigue : résultats de deux études de phase III

2022 · M. Dougados, P.J. Mease, et al. · Revue du Rhumatisme

Taux de rétablissement de la réponse avec l’ixékizumab après l’arrêt du traitement chez des patients atteints de spondyloarthrite axiale : résultats à la semaine 104 d’une étude de retrait randomisé, contrôlée versus placebo

2022 · R.B. Landewé, D. Poddubnyy, et al. · Revue du Rhumatisme

OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES

2022 · P.M. Machado, M. Schaefer, et al. · Annals of the Rheumatic Diseases

PDF

Pos0941 Long-term Clinical Outcomes of Certolizumab Pegol Treatment in Patients With Active Non‑radiographic Axial Spondyloarthritis Stratified by Baseline Mri and C-reactive Protein Status

2022 · P. Robinson, W.P. Maksymowych, et al. · Annals of the Rheumatic Diseases

PDF

Works count: 29

Citation count: 114

H-index: 2

I10-index: 1